Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up

MLA

Akbar N, Ashrafi, et al. “Five-Alpha Reductase Inhibitors in Men Undergoing Active Surveillance for Prostate Cancer: Impact on Treatment and Reclassification after 6 Years Follow-Up.” World Journal of Urology, vol. 39, no. 9, Oct. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........731e398adb5f16292412e33c830b3c4d&authtype=sso&custid=ns315887.

APA

Akbar N, A., Toshitaka, S., Arnaud, M., Thomas, C., Sunao, S., Tsuyoshi, I., Atsuko, I., Masakatsu, O., Sameer, C., Jie, C., Osamu, U., Duke, B., Inderbir S, G., & Andre Luis, A. (2020). Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up. World Journal of Urology, 39(9).

Chicago

Akbar N, Ashrafi, Shin Toshitaka, Marien Arnaud, Clifford Thomas, Shoji Sunao, Iwata Tsuyoshi, Iwata Atsuko, et al. 2020. “Five-Alpha Reductase Inhibitors in Men Undergoing Active Surveillance for Prostate Cancer: Impact on Treatment and Reclassification after 6 Years Follow-Up.” World Journal of Urology 39 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........731e398adb5f16292412e33c830b3c4d&authtype=sso&custid=ns315887.